{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:39:50Z","timestamp":1789925990359,"version":"4.0.1"},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T00:00:00Z","timestamp":1219190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:p>Paraneoplastic myasthenia gravis (MG) is accompanied by a neoplasm, usually thymoma. In patients with thymoma and a specific genetic make\u2010up, the paraneoplastic immune response develops further in thymic remnant or peripheral lymphatic tissue. Paraneoplastic MG and late\u2010onset MG (age \u2265 50\u2003years) share a similar immunological profile with high titin and ryanodine receptor (RyR) antibody prevalence. This profile is the most important predictor of clinical outcome in paraneoplastic MG. The presence of a thymoma <jats:italic>per se<\/jats:italic> does not cause more severe MG. MG severity is linked to the patient\u2019s immunological profile. Paraneoplastic MG causes a distinctive non\u2010limb symptom profile at MG onset, characterized by bulbar, ocular, neck, and respiratory symptoms. When the diagnosis of paraneoplastic MG is established, the neoplasm should be removed surgically. Pre\u2010thymectomy plasmapheresis or iv\u2010IgG should be considered in these patients to minimize post\u2010thymectomy MG exacerbation risk. Paraneoplastic MG usually continues after thymectomy. The pharmacological treatment of paraneoplastic MG does not differ from non\u2010paraneoplastic MG, except for tacrolimus that should be considered in difficult cases. Tacrolimus is an immunosuppressant acting specifically in RyR antibody positive patients through enhancing RyR\u2010related sarcoplasmic calcium release that in theory might be blocked by RyR antibodies, causing symptomatic relief in paraneoplastic MG.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2008.02242.x","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T13:05:10Z","timestamp":1219237510000},"page":"1029-1033","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Paraneoplastic myasthenia gravis: immunological and clinical aspects"],"prefix":"10.1111","volume":"15","author":[{"given":"G. O.","family":"Skeie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Romi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,5]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05186-2"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1255"},{"key":"e_1_2_3_4_2","first-page":"865","article-title":"Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis","volume":"134","author":"Marx A","year":"1989","journal-title":"American Journal of Pathology"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00145-5"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1998.00260.x"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)00134-A"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03442.x"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20340"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20577"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.12.1729"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0369-1"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0735"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg088"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1579"},{"key":"e_1_2_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05440.x"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20886"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.1999.650555.x"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20443"},{"key":"e_1_2_3_21_2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(19)39968-5","article-title":"Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum","volume":"265","author":"Zorzato F","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880131103"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1655::AID-MUS5>3.0.CO;2-F"},{"key":"e_1_2_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00374.x"},{"key":"e_1_2_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050604"},{"key":"e_1_2_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01785.x"},{"key":"e_1_2_3_27_2","first-page":"235","article-title":"Long\u2010term prognostic analysis of thymectomized patients with myasthenia gravis","volume":"115","author":"Liu W","year":"2002","journal-title":"Chinese Medical Journal"},{"key":"e_1_2_3_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2003.00678.x"},{"key":"e_1_2_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(83)90096-5"},{"key":"e_1_2_3_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-40755"},{"key":"e_1_2_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.phm.0000171169.79816.4c"},{"key":"e_1_2_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002275"},{"key":"e_1_2_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002277"},{"key":"e_1_2_3_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000098887.24618.A0"},{"key":"e_1_2_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(99)00052-4"},{"key":"e_1_2_3_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000125254.99397.68"},{"key":"e_1_2_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10472"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2008.02242.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2008.02242.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:40:05Z","timestamp":1696898405000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2008.02242.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,5]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1468-1331.2008.02242.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02242.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,5]]},"assertion":[{"value":"2008-09-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}